One Endocannabinoid System, Different Laws: The Global Hypocrisy of Cannabis Prohibition
Every human being on earth carries the same endocannabinoid system. The same CB1 receptors in the brain and central nervous system. The same CB2 receptors in the immune tissue. The same retrograde signalling mechanism. The same biological architecture that has been receiving cannabinoid molecules for 600 million years of vertebrate evolution. In Canada, a licensed dispensary sells cannabis for $8 a gram with age verification and quality control. In Germany, a doctor prescribes it. In South Africa, the Constitutional Court ruled that private use is a fundamental right. In Mauritius, an 81-year-old faces 25 years in prison for growing it at home for medical relief. The biology is identical. The laws are not. That gap is the hypocrisy this chapter exists to name.
The argument for cannabis prohibition has always rested on an implicit biological claim: that the plant poses a unique and universal danger that justifies extraordinary legal intervention. If that claim were true, it would apply equally in every jurisdiction on earth, because every human body contains the same endocannabinoid system, processes the same cannabinoid molecules through the same biological pathways, and would experience the same pharmacological risk. The claim is not true, and the global legislative landscape in 2026 proves it. Over forty jurisdictions have examined the evidence and concluded that cannabis prohibition is disproportionate, unjust, or simply wrong. They did not reach that conclusion by abandoning public health. They reached it by taking public health seriously. Mauritius has the same endocannabinoid system as Canada. It has different laws. This article documents both.
cannabis legal status country comparison 2026 Canada Germany Netherlands Uruguay South Africa Malta Thailand legalisation decriminalisation
Adult-use cannabis fully legal since October 2018 under the Cannabis Act. Licensed dispensaries operate nationwide with age verification, quality control, and lab-tested products. Medical cannabis available by prescription since 2001.
Price: approximately CAD $8 to $12 per gram in licensed dispensaries. Government collects excise tax. Youth use data: flat post-legalisation per Health Canada surveys.
Possession: Legal for adultsCannabisgesetz passed April 2024. Adults may possess up to 25g in public and 50g at home. Home cultivation of up to three plants permitted. Cannabis Social Clubs operational since July 2024.
Medical cannabis by prescription since 2017. Germany is the largest medical cannabis market in Europe. The Federal Health Ministry oversees quality and dosing standards for pharmaceutical-grade product.
Possession: Legal for adultsFirst country in the world to fully legalise cannabis at national level. State-controlled market since 2013. Citizens purchase from pharmacies at a regulated price. Home cultivation of up to six plants permitted.
Price: approximately USD $1.30 per gram at state pharmacies. The regulated price was specifically designed to undercut the illegal market and eliminate criminal profit margins entirely.
Possession: Legal for citizensMedical cannabis available by NHS and private prescription since November 2018 for qualifying conditions including chronic pain, epilepsy, and multiple sclerosis spasticity. Recreational use remains Class B.
The Judicial Committee of the Privy Council, Mauritius's final court of appeal, sits in a country where a patient with the 81-year-old's conditions could obtain a legal prescription. The JCPC applies Mauritian law, not English law.
Medical: Legal by prescriptionThailand removed cannabis from its narcotic drugs list in June 2022, becoming the first Asian country to do so. Medical and wellness use is permitted. Full recreational regulation is pending.
Thailand is a Buddhist country with conservative traditions. Its decision was driven by medical evidence and economic opportunity. The cultural argument against cannabis reform does not belong exclusively to any religious or traditional framework.
Recreational: DecriminalisedMalta became the first EU member state to legalise recreational cannabis in December 2021. Adults may possess up to 7g and grow up to four plants at home. Cannabis clubs of up to 500 members operate under licence.
Malta is a small Catholic island nation of approximately 520,000 people, roughly four times the population of Mauritius. The small island argument against cannabis reform has been tested in Malta. It did not hold.
Possession: Legal for adultsSource of Mauritian private law through the Code Civil Mauricien. Medical cannabis pilot programme since 2021 under the ANSM. Fixed penalty fine of 200 euros for personal possession since 2019. Moving toward permanent medical framework in 2026.
France produces approximately 40% of the EU's total industrial hemp. CBD products legal and widely sold. The legal tradition Mauritius inherited from France has moved significantly toward harm reduction.
Personal possession: Fixed fineDangerous Drugs Act 2000. Personal cultivation: up to 25 years. Personal possession: up to 2 years. The 2022 amendment that would have permitted medical access has not been proclaimed. No legal pathway to cannabis exists for any patient.
An 81-year-old is before the Supreme Court facing 25 years for personal medical cultivation. Two Grade 6 pupils were placed under police investigation for cannabis on 27 May 2026. They are approximately 11 years old.
Cultivation: Up to 25 yearsUN CND December 2020 cannabis reclassification Schedule IV removed WHO recommendation medical scientific value Mauritius response 2022 amendment
On 2 December 2020, the UN Commission on Narcotic Drugs voted 27 to 25 to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs. Schedule IV had classified cannabis alongside heroin as having no accepted medical use and high abuse potential. The removal was recommended by the World Health Organisation following a critical review that concluded cannabis and cannabis resin do not belong in Schedule IV.
The 1961 Single Convention is the international treaty that formed the legal foundation for cannabis prohibition globally, including the framework underpinning the Dangerous Drugs Act 2000 in Mauritius. The UN itself has now formally removed the basis for that classification. Mauritius is no longer required by international treaty to maintain cannabis in its most restrictive category.
The Mauritian parliament acknowledged this by passing the 2022 amendment. The Mauritian executive has not acknowledged it by proclaiming the amendment. The international consensus has moved. Mauritius has one foot in 2020 and one foot in 1961, simultaneously.
South Africa cannabis constitutional right private use 2018 Lesotho Zimbabwe Rwanda medical Africa cannabis reform Mauritius regional comparison
South Africa, 2018: The Constitutional Court ruled in Minister of Justice and Constitutional Development v Prince that prohibiting private cannabis use, cultivation, and possession by adults in private was unconstitutional, violating the right to privacy. The South African Constitutional Court moved when parliament would not. This is the direct regional precedent for the 81-year-old's case before the Mauritian Supreme Court.
Lesotho, 2017: Became the first African country to license medical cannabis cultivation. Now a significant export supplier to medical markets in Germany and the United Kingdom. A landlocked mountain kingdom with limited agricultural resources identified cannabis as an economic opportunity before most of sub-Saharan Africa.
Zimbabwe, 2018: Legalised medical cannabis cultivation and issued its first commercial licences in 2020. The government treated cannabis as an agricultural commodity with significant export revenue potential.
Rwanda, 2021: Legalised medical cannabis cultivation for export. Part of the broader East African recognition of cannabis as a pharmaceutical and agricultural commodity.
Mauritius brands itself as a sophisticated services hub for the African continent. Its cannabis policy in 2026 is to the right of South Africa's 2018 constitutional court ruling, to the right of Lesotho's 2017 licensing framework, and to the right of Zimbabwe's 2018 medical legalisation. The regional context does not support the Mauritian state's position. It contradicts it at every point.
In Canada, an elderly patient with diabetic neuropathy receives a medical cannabis prescription, purchases lab-tested product from a licensed pharmacy at approximately CAD $8 per gram, and pays excise tax whose revenue funds the public health system treating his other conditions.
In Germany, the same patient sees a specialist, receives a prescription, and accesses pharmaceutical-grade cannabis through the national health insurance system. Dosage controlled. Product tested. Treatment documented.
In South Africa, the same patient may cultivate cannabis in his own garden for personal use as a constitutional right confirmed by the highest court in the country in 2018.
In Mauritius, the same patient, aged 81, is before the Supreme Court facing up to 25 years in prison for cultivating the same plant in his own home for his own medical relief. The plant is identical. The molecule is identical. The endocannabinoid system receiving it is identical. The law is catastrophically different. That difference is not pharmacology. It is politics. And it is costing an 81-year-old man his liberty and his peace of mind in the final years of his life.
The biology does not change at the border. Every Mauritian citizen has the same endocannabinoid system as every Canadian, every German, every South African. The plant produces the same therapeutic effect in every body. The law produces a catastrophically different consequence in Mauritius alone. That is not pharmacology. That is politics.
Since the Dangerous Drugs Act 2000 was passed, Canada has fully legalised cannabis. Germany has legalised it. Uruguay legalised it in 2013. Malta became the first EU state to legalise it in 2021. Thailand decriminalised it in 2022. South Africa's Constitutional Court declared private use a constitutional right in 2018. The UN Commission on Narcotic Drugs removed cannabis from its most restrictive schedule in 2020. Lesotho, Zimbabwe, and Rwanda have legalised medical cultivation on the African continent.
In the same period, Mauritius passed a 2022 amendment it did not proclaim. The ADSU uprooted approximately 60,000 plants per year. Cannabis street prices rose to Rs 3,000 per gram. The synthetic drug market expanded until Mauritius was ranked number one in the synthetic drug trade in Southern Africa. 652 adolescents were hospitalised for drug-related problems in five years. An 81-year-old is in court.
The world moved because the evidence moved. Mauritius stayed because the political will did not move. Chapter Five documents the human cost of that decision, life by life.
Canada: Cannabis Act, SC 2018, c. 16. Health Canada, available at laws-lois.justice.gc.ca.
Germany: Cannabisgesetz (Cannabis Act), Bundesgesetzblatt 2024. bundesgesundheitsministerium.de.
Uruguay: Law 19.172, "Marihuana y sus derivados," 2013. IRCCA, available at ircca.gub.uy.
United Kingdom: Misuse of Drugs Regulations 2001 as amended November 2018. House of Commons Library CBP-8355, 2026.
Thailand: Narcotics Act Amendment, June 2022. Thai Food and Drug Administration.
Malta: Authority on the Responsible Use of Cannabis Act, December 2021. Maltese Government Gazette.
France: ANSM medical cannabis pilot 2021. Fixed penalty fine: Law of 23 March 2019. Cannabis Europa France guide, April 2026.
South Africa: Minister of Justice and Constitutional Development v Prince, Constitutional Court, Case CCT 108/17, 18 September 2018. Available at saflii.org.
Lesotho, Zimbabwe, Rwanda: Lesotho Narcotics Bureau licence 2017. Zimbabwe Statutory Instrument 62 of 2018. Rwanda cabinet resolution on medical cannabis export, 2021.
UN CND reclassification: United Nations Commission on Narcotic Drugs, 63rd Session, 2 December 2020. WHO ECDD critical review of cannabis, 2019. Vote: 27 to 25. Available at unodc.org.
This is the first article of Chapter Five: The Hypocrisy, in The Colonised Plant: The Cannabis Edition, June 2026. The next article examines the UDHR human rights case against cannabis prohibition. The complete edition is published at themeridian.info/june-2026.
Add comment
Comments